{"id":"W2289712604","doi":"10.1016/s0140-6736(16)00561-4","title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3714,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; Genentech","keywords":"Atezolizumab; Metastatic Urothelial Carcinoma; Medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Internal medicine; Population; Chemotherapy; Cancer; Progressive disease; Cohort; Urology; Immunotherapy; Bladder cancer; Pembrolizumab; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001609845,0.001131877,0.002494996,0.0002158093,0.0002941144,0.0009740415,0.0006431972,0.001503405,0.002324739],"category_scores_gemma":[0.001514063,0.0004676589,0.002511558,0.0003281804,0.0007366419,0.001045024,0.0003703164,0.003543951,0.0004148162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007797382,"about_ca_system_score_gemma":0.0007255158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007895728,"about_ca_topic_score_gemma":0.002519669,"domain_scores_codex":[0.9996052,0.0001967923,0.0000221981,0.00007484161,0.00002311689,0.00007791475],"domain_scores_gemma":[0.9993256,0.0001876747,0.0001531273,0.00005684896,0.00003864253,0.0002381952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9174848,0.006005402,0.00518292,0.001230075,0.002774855,0.0001366521,0.0001689661,0.001480031,0.00564108,0.0001669474,0.002756187,0.05697203],"study_design_scores_gemma":[0.8803462,0.1046643,0.01044727,0.00005598766,0.001081004,0.0001653942,0.00006314921,0.0007486481,0.0005579948,0.0002234956,0.001620087,0.00002639895],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909042,0.00558232,0.0002499976,0.0009660356,0.000341714,0.0004763141,0.0005763645,0.00004505185,0.0008579011],"genre_scores_gemma":[0.9915829,0.002938966,0.0005889465,0.001128807,0.0002279587,0.0005418695,0.001128521,0.00001629236,0.001845804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002494996,"threshold_uncertainty_score":0.008513808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02430309705466145,"score_gpt":0.2865667378326373,"score_spread":0.2622636407779759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}